TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
APMD

Apnimed, Inc.

Healthcare · Biotechnology

21.50$ -4.6% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement APMD
Line item Q1 25 Q2 25 Q1 26 Q2 26
100.0% 100.0% 100.0% 100.0%
42.1% 10.1% 2.5% 10.0%
57.9% 89.9% 97.5% 90.0%
749.2% 93.3% 9.6% 82.0%
174.7% 31.3% 7.7% 104.9%
965.9% 134.7% 19.8% 196.9%
-865.9% -34.7% 80.2% -96.9%
-852.2% -32.9% 83.0% 1,044.0%
-914.9% -406.0% 83.0% 1,042.5%
-865.7% -34.7% 80.2% -96.8%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?